Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryogo Minamimoto

Showing results (51-60 of 148) with videos related to

Pageof 15
Sort By:
Clinical Nuclear Medicine|February 26, 2016
A Prospective, Matched Comparison Study of SUV Measurements From Time-of-Flight Versus Non-Time-of-Flight PET/CT ScannersHolly M Thompson, Ryogo Minamimoto, Mehran Jamali, et al.
Nuclear Medicine Communications|August 31, 2011
Cut-off value for normal versus abnormal right-to-left shunt percentages using (99m)Tc-macroaggregated albuminKimiteru Ito, Kyoko Kurihara, Akihiko Ishibashi, et al.
Plos One|January 20, 2017
Conspicuity of Malignant Lesions on PET/CT and Simultaneous Time-Of-Flight PET/MRIRyogo Minamimoto, Andrei Iagaru, Mehran Jamali, et al.
Japanese Journal of Radiology|March 4, 2025
Imaging insights of FDG-PET from neonates to infantsRyogo Minamimoto, Yumi Abe, Shinichiro Kamiya, et al.
Annals of Nuclear Medicine|September 3, 2014
Lesion-based analysis of (18)F-FDG uptake and (111)In-Pentetreotide uptake by neuroendocrine tumorsKazuo Kubota, Momoko Okasaki, Ryogo Minamimoto, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 13, 2021
Efficacy of cell proliferation imaging with 4DST PET/CT for predicting the prognosis of patients with esophageal cancer: a comparison study with FDG PET/CTMasatoshi Hotta, Ryogo Minamimoto, Jun Toyohara, et al.
Journal of Neurosurgery|July 6, 2023
Clinical decision-making based on 11C-methionine PET in recurrent Cushing's disease with equivocal MRI findingsAtsushi Ishida, Koichiro Kaneko, Ryogo Minamimoto, et al.
Annals of Nuclear Medicine|May 5, 2021
Prognostic value of <sup>18</sup>F-FDG PET/CT with texture analysis in patients with rectal cancer treated by surgeryMasatoshi Hotta, Ryogo Minamimoto, Yoshimasa Gohda, et al.
Clinical Nuclear Medicine|April 13, 2013
18F-FDG PET/CT findings preceded elevation of serum proteinase 3 antineutrophil cytoplasmic antibodies in Wegener granulomatosisKimiteru Ito, Ryogo Minamimoto, Hiroyuki Yamashita, et al.
Annals of Nuclear Medicine|January 15, 2009
Accelerator mass spectrometry analysis of background (14)C-concentrations in human blood: aiming at reference data for further microdosing studiesRyogo Minamimoto, Yoshimi Hamabe, Teiji Miyaoka, et al.
Pageof 15

Showing results (51-60 of 148) with videos related to

Sort By:
Pageof 15
Clinical Nuclear Medicine|February 26, 2016
A Prospective, Matched Comparison Study of SUV Measurements From Time-of-Flight Versus Non-Time-of-Flight PET/CT ScannersHolly M Thompson, Ryogo Minamimoto, Mehran Jamali, et al.
Nuclear Medicine Communications|August 31, 2011
Cut-off value for normal versus abnormal right-to-left shunt percentages using (99m)Tc-macroaggregated albuminKimiteru Ito, Kyoko Kurihara, Akihiko Ishibashi, et al.
Plos One|January 20, 2017
Conspicuity of Malignant Lesions on PET/CT and Simultaneous Time-Of-Flight PET/MRIRyogo Minamimoto, Andrei Iagaru, Mehran Jamali, et al.
Japanese Journal of Radiology|March 4, 2025
Imaging insights of FDG-PET from neonates to infantsRyogo Minamimoto, Yumi Abe, Shinichiro Kamiya, et al.
Annals of Nuclear Medicine|September 3, 2014
Lesion-based analysis of (18)F-FDG uptake and (111)In-Pentetreotide uptake by neuroendocrine tumorsKazuo Kubota, Momoko Okasaki, Ryogo Minamimoto, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 13, 2021
Efficacy of cell proliferation imaging with 4DST PET/CT for predicting the prognosis of patients with esophageal cancer: a comparison study with FDG PET/CTMasatoshi Hotta, Ryogo Minamimoto, Jun Toyohara, et al.
Journal of Neurosurgery|July 6, 2023
Clinical decision-making based on 11C-methionine PET in recurrent Cushing's disease with equivocal MRI findingsAtsushi Ishida, Koichiro Kaneko, Ryogo Minamimoto, et al.
Annals of Nuclear Medicine|May 5, 2021
Prognostic value of <sup>18</sup>F-FDG PET/CT with texture analysis in patients with rectal cancer treated by surgeryMasatoshi Hotta, Ryogo Minamimoto, Yoshimasa Gohda, et al.
Clinical Nuclear Medicine|April 13, 2013
18F-FDG PET/CT findings preceded elevation of serum proteinase 3 antineutrophil cytoplasmic antibodies in Wegener granulomatosisKimiteru Ito, Ryogo Minamimoto, Hiroyuki Yamashita, et al.
Annals of Nuclear Medicine|January 15, 2009
Accelerator mass spectrometry analysis of background (14)C-concentrations in human blood: aiming at reference data for further microdosing studiesRyogo Minamimoto, Yoshimi Hamabe, Teiji Miyaoka, et al.
Pageof 15